Rabies remains a significant public health challenge across India. Consequently, clinicians must understand rabies vaccine antibody persistence to manage at-risk patients effectively. A recent retrospective cohort study from Thiruvananthapuram provides new evidence regarding long-term immunity following standard vaccination protocols.

Researchers analyzed 150 participants at a preventive clinic in Kerala. They estimated serum antibody titers using the Rapid Fluorescent Foci Inhibition Test (RFFIT). Notably, 92.7% of participants maintained protective levels of at least 0.5 IU/ml. The average titer reached 3.81 IU/ml. This demonstrates that anti-rabies vaccination provides robust and long-lasting protection for the majority of individuals.

Optimizing Booster Intervals for Rabies Vaccine Antibody Persistence

The study explored factors influencing these titers. Regression analysis identified two key predictors of high antibody levels. First, a shorter duration since the last vaccination naturally correlated with higher titers. Second, the intramuscular route showed higher absolute values compared to the intradermal route. However, both schedules successfully achieved comparable protective thresholds for the participants. This finding supports the reliability of intradermal regimens widely used in India.

Importantly, researchers used ROC curve analysis to determine the best time for re-vaccination. They identified five years as the optimal cut-off for a booster dose. This finding simplifies clinical protocols for individuals with frequent animal exposure. Furthermore, it reinforces the efficacy of current vaccination schedules in the Indian context. Essentially, the achievement of protective titers appears universal regardless of the administration route.

Frequently Asked Questions

Is the intradermal rabies vaccination as effective as the intramuscular route?

Yes. The study confirmed that while the intramuscular route may produce slightly higher titers, both intradermal and intramuscular schedules are universally effective. Both methods consistently achieve protective antibody levels above the 0.5 IU/ml threshold.

When should a person consider a rabies booster dose?

Based on the ROC analysis from this cohort, five years after the last dose serves as an optimal cut-off for a booster dose. This interval helps maintain protective immunity in individuals at continued risk.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always consult a qualified healthcare professional for personal medical concerns. Refer to the latest local and national guidelines for clinical practice.

References

1. Suresh R et al. Antibody response following rabies vaccination: a retrospective cohort study from a tertiary centre in Kerala, India. Trans R Soc Trop Med Hyg. 2026 May 09. doi: undefined. PMID: 42104810.


2. World Health Organization. Rabies vaccines: WHO position paper – April 2018. Weekly Epidemiological Record. 2018;93(16):201-219.


3. National Centre for Disease Control (NCDC). National Guidelines on Rabies Prophylaxis. Ministry of Health and Family Welfare, Government of India; 2022.